Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled glutathione for cystic fibrosis
2005-003870-88Phase 2Completed
- Sponsor
- Mukoviszidose Institut
- Start
- Aug 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glutathione in cystic fibrosis (CF) (2 arms), sponsored by Mukoviszidose Institut. Started Aug 2006; status: completed.
02
Drugs
glutathione
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2005-003870-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003870-88.